Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia. [electronic resource]
Producer: 20110317Description: 5659-66 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Antiemetics -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cytarabine -- adverse effects
- Drug Administration Schedule
- Female
- Humans
- Isoquinolines -- adverse effects
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Nausea -- prevention & control
- Ondansetron -- adverse effects
- Palonosetron
- Quinuclidines -- adverse effects
- Serotonin Antagonists -- therapeutic use
- Vomiting -- prevention & control
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.